vaccine trials

VLA15 May be the First Vaccine Against Lyme Disease

Valvena is Developing a Lyme Disease Vaccine

Thousands of Americans and Europeans develop Lyme disease every year. Biotech company Valneva has been developing what may be the world's first vaccine, VLA15, against Lyme disease.
Severe Adverse Event of One Volunteer Puts Oxford Vaccine Trials on Hold

AstraZeneca Temporarily Stops Phase 3 of Global Vaccine Trials

AstraZeneca, already in the late-stage of their phase three vaccine trials, had to pause all trials due to one volunteer developing an unexplained illness. Alongside other Operation Warp Speed Companies, the biopharmaceutical company signed a joint pledge to properly follow scientific and ethical standards in developing a coronavirus vaccine.

Recommended Stories

Real Time Analytics